<Suppliers Price>

Toloxatone

Names

[ CAS No. ]:
29218-27-7

[ Name ]:
Toloxatone

[Synonym ]:
5-(hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone Humoryl
Toloxatone
5-(Hydroxymethyl)-3-(m-tolyl)oxazolidin-2-one
5-hydroxymethyl-3-(3-methylphenyl)-2-oxazolidinone
ToloxatonetoloxatonetoloxatoneToloxatone
Perenum
EINECS 249-522-2
MFCD00865391
Humoryl
5-(hydroxymethyl)-3-m-tolyl-2-oxazolidinone
5-Hydroxymethyl-3-(3-methylphenyl)oxazolidin-2-one

Biological Activity

Chemical & Physical Properties

[ Density]:
1.245g/cm3

[ Boiling Point ]:
358.9ºC at 760mmHg

[ Melting Point ]:
76°

[ Molecular Formula ]:
C11H13NO3

[ Molecular Weight ]:
207.23

[ Flash Point ]:
170.9ºC

[ Exact Mass ]:
207.09000

[ PSA ]:
49.77000

[ LogP ]:
1.37750

[ Vapour Pressure ]:
8.9E-06mmHg at 25°C

[ Index of Refraction ]:
1.57

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
DMSO: >10mg/mL

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RQ2867500
CHEMICAL NAME :
2-Oxazolidinone, 5-hydroxymethyl-3-(m-tolyl)-
CAS REGISTRY NUMBER :
29218-27-7
LAST UPDATED :
199612
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C11-H13-N-O3
MOLECULAR WEIGHT :
207.25
WISWESSER LINE NOTATION :
T5NVOTJ AR C1& D1Q

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1225 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - coma Lungs, Thorax, or Respiration - other changes
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 1,569,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1300 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - coma Lungs, Thorax, or Respiration - other changes
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 1,569,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
650 mg/kg
TOXIC EFFECTS :
Behavioral - altered sleep time (including change in righting reflex) Behavioral - coma Lungs, Thorax, or Respiration - other changes
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 1,569,1976

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
22

[ RIDADR ]:
UN 3249

[ RTECS ]:
RQ2867500

[ Packaging Group ]:
III

[ Hazard Class ]:
6.1(b)

[ HS Code ]:
2934999090

Customs

[ HS Code ]: 2934999090

[ Summary ]:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Articles

5-(2-Aminopropyl)indole (5-IT): a psychoactive substance used for recreational purposes is an inhibitor of human monoamine oxidase (MAO).

Drug Test. Anal. 6(7-8) , 607-13, (2014)

5-(2-Aminopropyl)indole (5-IT) is a psychoactive compound that has recently been associated with several fatal and non-fatal intoxications in a number of European countries. There are indications that...

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

J. Pharmacol. Exp. Ther. 356 , 483-92, (2016)

According to the catecholaldehyde hypothesis, the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) contributes to the loss of nigrostriatal dopaminergic neurons in Parkinson's disease...

A double-blind comparison of moclobemide and toloxatone in out-patients presenting a major depressive disorder.

Psychopharmacology 106 Suppl , S118-9, (1992)

A double-blind comparison of moclobemide and toloxatone was performed in adult out-patients diagnosed as suffering from a major depressive disorder. Parallel groups of patients received moclobemide, 4...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.